CI

At a glance

ClinicalIndex Comparison Record
Phase 4Completed· 34 enrolled
Drug / intervention
Testosterone Undecanoate +1 moredrug
Likely dose
Testosterone Undecanoate 750 mgfrom record
Structured eligibility isn't available for this trial yet — see the full criteria in the Eligibility tab below.

Standardized by ClinicalIndex from the ClinicalTrials.gov record · verify against the source.

Search/NCT04120363
NCT04120363Phase 4Completed
CompareCT.gov

A Randomized, Double-blind, Placebo Controlled Trial of Testosterone Undecanoate for Optimizing Physical and Cognitive Performance During Military Operations (OPS II)

Pennington Biomedical Research Center·interventional·Posted Oct 9, 2019·Updated Oct 7, 2022

In Brief

A Phase 4 clinical trial evaluating Testosterone Undecanoate and Sesame Oil for Caloric Restriction and 2 related conditions. Completed, enrolled 34 participants across 1 site.

Detailed Summary

The objective of this study is to determine the effects of a single dose of testosterone undecanoate during and in recovery from simulated operational stress.

Study Details

Study Typeinterventional
Allocation--
Masking--
Primary Purpose--
ConditionsCaloric Restriction, Exercise, Sleep
CountriesUnited States
CollaboratorsUnited States Army Research Institute of Environmental Medicine, United States Department of Defense, University of Arkansas

Timeline

Phase 4CompletedFinished
2020202120222023202420252026
First PostedOct 9, 2019
Enrollment StartSep 23, 2019
Primary CompletionJul 8, 2021
TodayJul 2, 2026
Enrollment to primary: 1.8 yearsPosted 6.7 years ago

Interventions

Testosterone Undecanoatedrug

single intramuscular injection of 750 mg testosterone undecanoate

Sesame Oildrug

single intramuscular injection of 750 mg sesame oil solution